Current status of sympathectomy
10.3760/cma.j.issn.1001-4497.2018.02.017
- VernacularTitle:微创交感神经切除术的应用现状
- Author:
Jinghan SHI
1
;
Jian CAI
;
Dong XIE
;
Gening JIANG
Author Information
1. 200433,同济大学附属上海市肺科医院胸外科
- From:
Chinese Journal of Thoracic and Cardiovascular Surgery
2018;34(2):125-128
- CountryChina
- Language:Chinese
-
Abstract:
The postganglionic fibers arising from sympathetic nervous system dominate some activities in human body,such as secretion of sweat glands,vasoconstriction and pain transmission.While block its transmission can treat some certain diseases.Now sympathectomy is mainly applied in treating primary hyperhidrosis,peripheral artery disease (thromboangiitis obliteran,Raynaud's diseases),long Q-T syndrome,and intractable abdominal pain,and video-assisted surgery is the mainstream.Basing on the ensurement of efficacy,reasonable extension of resection range can reduce the incidence of compensatory hyperhidrosis.Primary hyperhidrosis,which applying widely,is the best indication for this sympathectomy.For peripheral artery disease (thromboangiitis obliteran,Raynaud' s diseases),long Q-T syndmme,and intractable abdominal pain,sympathectomy should be taken into consideration when drug treatment fails or taboos.Sympathectomy will become more minimally invasive as well as improve living quality for patients in the future.
